|
業務類別
|
Biotechnology |
|
業務概覽
|
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains. |
| 公司地址
| 51 Sleeper Street, Boston, MA, USA, 02210 |
| 電話號碼
| +1 617 865-9628 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.odysseytx.com |
| 員工數量
| 151 |
| Ms. Jolie M. Siegel |
Executive Vice President, General Counsel and Secretary |
-- |
04/05/2026 |
| Mr. Jason Haas |
Chief Financial Officer and Principal Accounting Officer |
-- |
04/05/2026 |
| Dr. Gary D. Glick, PhD |
President, Chief Executive Officer and Director |
-- |
04/05/2026 |
| Dr. Natalie Dales, PhD |
Chief of Research Operations and Portfolio Strategy |
-- |
04/05/2026 |
| Dr. Anthony Opipari, M.D. |
Interim Chief Medical Officer and Executive Vice President, Translational Medicine |
-- |
04/05/2026 |
| Mr. Collin Todd |
Senior Vice President, Strategy and Business Development |
-- |
04/05/2026 |
|
|
| Dr. Carl L. Gordon, C.F.A.,PhD |
Independent Director |
04/05/2026 |
| Mr. Ian F. Smith |
Independent Director |
04/05/2026 |
| Mr. Timothy P. Walbert |
Independent Director |
04/05/2026 |
| Dr. Jeffrey M Leiden, PhD |
Chairman of the Board |
04/05/2026 |
| Ms. Jill Carroll, M.S. |
Independent Director |
04/05/2026 |
| Dr. Paulina Hill, M.D. |
Independent Director |
04/05/2026 |
| Dr. Carolyn Ng, PhD |
Independent Director |
04/05/2026 |
| Ms. Valerie Odegard,, PhD |
Independent Director |
04/05/2026 |
| Dr. Shelley Chu, M.D.,PhD |
Independent Director |
04/05/2026 |
| Dr. Nia Tatsis, PhD |
Independent Director |
04/05/2026 |
| Dr. Gary D. Glick, PhD |
President, Chief Executive Officer and Director |
04/05/2026 |
| Mr. Nan Li |
Independent Director |
04/05/2026 |
| Ms. Ksenija Pavletic |
Independent Director |
04/05/2026 |
|
|
|
|
